Vessella RL - Search Results

1

Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.

Siltanen S, Wahlfors T, Schindler M, Saramäki OR, Mpindi JP, Latonen L, Vessella RL, Tammela TL, Kallioniemi O, Visakorpi T, Schleutker J. Siltanen S, et al. Among authors: vessella rl. PLoS One. 2011;6(10):e26595. doi: 10.1371/journal.pone.0026595. Epub 2011 Oct 20. PLoS One. 2011. PMID: 22028916 Free PMC article.

2

MicroRNA expression profiling in prostate cancer.

Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. Porkka KP, et al. Among authors: vessella rl. Cancer Res. 2007 Jul 1;67(13):6130-5. doi: 10.1158/0008-5472.CAN-07-0533. Cancer Res. 2007. PMID: 17616669

3

The miR-15a-miR-16-1 locus is homozygously deleted in a subset of prostate cancers.

Porkka KP, Ogg EL, Saramäki OR, Vessella RL, Pukkila H, Lähdesmäki H, van Weerden WM, Wolf M, Kallioniemi OP, Jenster G, Visakorpi T. Porkka KP, et al. Among authors: vessella rl. Genes Chromosomes Cancer. 2011 Jul;50(7):499-509. doi: 10.1002/gcc.20873. Epub 2011 Mar 31. Genes Chromosomes Cancer. 2011. PMID: 21472816

4

Amplification of the 9p13.3 chromosomal region in prostate cancer.

Latonen L, Leinonen KA, Grönlund T, Vessella RL, Tammela TL, Saramäki OR, Visakorpi T. Latonen L, et al. Among authors: vessella rl. Genes Chromosomes Cancer. 2016 Aug;55(8):617-25. doi: 10.1002/gcc.22364. Epub 2016 May 2. Genes Chromosomes Cancer. 2016. PMID: 27074291

5

Genetic aberrations in prostate cancer by microarray analysis.

Saramäki OR, Porkka KP, Vessella RL, Visakorpi T. Saramäki OR, et al. Among authors: vessella rl. Int J Cancer. 2006 Sep 15;119(6):1322-9. doi: 10.1002/ijc.21976. Int J Cancer. 2006. PMID: 16642477

6

Human pHyde is not a classical tumor suppressor gene in prostate cancer.

Porkka KP, Nupponen NN, Tammela TL, Vessella RL, Visakorpi T. Porkka KP, et al. Among authors: vessella rl. Int J Cancer. 2003 Sep 20;106(5):729-35. doi: 10.1002/ijc.11278. Int J Cancer. 2003. PMID: 12866033

7

RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.

Porkka KP, Tammela TL, Vessella RL, Visakorpi T. Porkka KP, et al. Among authors: vessella rl. Genes Chromosomes Cancer. 2004 Jan;39(1):1-10. doi: 10.1002/gcc.10289. Genes Chromosomes Cancer. 2004. PMID: 14603436

8

Expression of androgen receptor coregulators in prostate cancer.

Linja MJ, Porkka KP, Kang Z, Savinainen KJ, Jänne OA, Tammela TL, Vessella RL, Palvimo JJ, Visakorpi T. Linja MJ, et al. Among authors: vessella rl. Clin Cancer Res. 2004 Feb 1;10(3):1032-40. doi: 10.1158/1078-0432.ccr-0990-3. Clin Cancer Res. 2004. PMID: 14871982

9

The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.

Saramäki OR, Tammela TL, Martikainen PM, Vessella RL, Visakorpi T. Saramäki OR, et al. Among authors: vessella rl. Genes Chromosomes Cancer. 2006 Jul;45(7):639-45. doi: 10.1002/gcc.20327. Genes Chromosomes Cancer. 2006. PMID: 16575874

10

Screening of genetic and expression alterations of SRC1 gene in prostate cancer.

Mäki HE, Waltering KK, Wallén MJ, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Visakorpi T. Mäki HE, et al. Among authors: vessella rl. Prostate. 2006 Sep 15;66(13):1391-8. doi: 10.1002/pros.20427. Prostate. 2006. PMID: 16894533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters